Dr. Quentin Felty, associate professor at Florida International University Robert Stempel College of Public Health and Social Work, has been awarded a $439,500 grant from the National Heart, Lung, and Blood Institute (NHLBI) to study stem cells lining the lung vessel wall in persons with pulmonary arterial hypertension (PAH).
According to lung.org, pulmonary arterial hypertension affects about 15-50 people per million in the U.S. PAH remains a serious disease with significant morbidity and mortality because current therapies are currently focused on improving heart function and pulmonary blood flow rather than the growth of cells within the vessels.
Working with the Pulmonary Hypertension Breakthrough Initiative (PHBI) Research Network, the collaborating agency for clinical samples, the research will study how stem cells become abnormal and look for ways to treat the abnormal growths.
The goal is to find treatments for PAH that may use interventions and medications that are currently approved and available on the market, most likely those used to treat cancers.
“Given that PAH and cancer cells share stem cell similarities, our research project brings an emerging paradigm in PAH pathology to potentially exploit therapeutic strategies used in cancer to treat PAH, said Dr. Felty, “Essentially, new PAH therapies can come from existing drugs.”
The project includes a National Institutes of Health (NIH) Academic Research Enhancement Award (AREA) grant that will support the research while exposing students to project and strengthening the research environment at Stempel College.Friday Letter Submission